Lol - I'll tell you what another risk is, acquiring another biotech and inheriting a fat pipeline that needs a lot of $$$ thrown at it despite already having some very eligible drug candidates. Was that savvy? Maybe, we'll see.
It has been straight carnage for the last while at IHL. We will have to wait and see whether we look back in the future at this raise being a savvy move.
General discussion, page-14984
-
- There are more pages in this discussion • 5,478 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)